Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SOCS6 |
| Upstream (Parents) |
|---|
| (<<) HSPA13 → SOCS6 |
| (<<) ZFY///ZFX → SOCS6 |
| (<<) ZNF45 → SOCS6 |
| (<<) MIA3 → SOCS6 |
| Downstream (Children) |
|---|
| SOCS6 → DDX43 (>>) |
| SOCS6 → KIAA0408 (>>) |
| SOCS6 → FLJ11292 (>>) |
| SOCS6 → F2RL2 (>>) |
| SOCS6 → GRIA3 (>>) |
| SOCS6 → NANOG (>>) |
| SOCS6 → ASTN1 (>>) |
| SOCS6 → BAG2 (>>) |
| SOCS6 → BLK (>>) |
| SOCS6 → MTMR3 (>>) |
| SOCS6 → CDC14B (>>) |
| SOCS6 → CCIN (>>) |
| SOCS6 → SMEK1 (>>) |
| SOCS6 → INPP5B (>>) |
| SOCS6 → HSPA13 (>>) |
| SOCS6 → PRM2 (>>) |
| SOCS6 → CDKAL1 (>>) |
| SOCS6 → MED28 (>>) |
| SOCS6 → ZNF238 (>>) |
| SOCS6 → PMS2L3 (>>) |
| SOCS6 → C11orf9 (>>) |
| SOCS6 → UBQLN4 (>>) |
| SOCS6 → PPP2R2D (>>) |
| SOCS6 → C7orf63 (>>) |
| SOCS6 → FRS2 (>>) |
| SOCS6 → KIAA0090 (>>) |
| SOCS6 → ABL2 (>>) |
| SOCS6 → HS6ST1 (>>) |
| SOCS6 → ZFY///ZFX (>>) |
| SOCS6 → NRIP1 (>>) |
| SOCS6 → ALPK1 (>>) |
| SOCS6 → PVR (>>) |
| SOCS6 → ZNF45 (>>) |
| SOCS6 → ISYNA1 (>>) |
| SOCS6 → KIR2DS2///KIR2DS4///KIR2DS1 (>>) |
| SOCS6 → AK2 (>>) |
| SOCS6 → ALMS1 (>>) |
| SOCS6 → LRRC40 (>>) |
| SOCS6 → FEM1B (>>) |
| SOCS6 → DAPP1 (>>) |
| SOCS6 → STAM2 (>>) |
